Palle Valentiner-Branth

Palle Valentiner-Branth

Kontakt

Palle Valentiner-Branth, Afdelingschef, Infektionsepidemiologi og Forebyggelse
T. 32683269 @. pvb@ssi.dk

Forskningsområder

Infektionsepidemiologi. Vaccinologi. National epidemiologisk overvågning af infektioner samt vaccinationstilslutning (herunder determinanter for vaccination) og effekt og sikkerhed af vaccinationsprogrammer.

Har flere års erfaring fra store befolkningsbaserede forskningsprojekter i udviklingslande med fokus på at øge forståelsen for naturhistorien af og i at forbedre behandlingen af episoder med diarre og lungebetændelse.

PubMed link:

https://pubmed.ncbi.nlm.nih.gov/?term=Valentiner-Branth+P%20%0d

Ansvarsområder

Afdelingschef i afdeling for infektionsepidemiologi og forebyggelse.

Publikationer

Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study.
Hansen CH, Moustsen-Helms IR, Rasmussen M, Søborg B, Ullum H, Valentiner-Branth P.
Lancet Infect Dis. 2024 Feb;24(2):e73-e74. doi: 10.1016/S1473-3099(23)00746-6. Epub 2024 Jan 5.
PMID: 38190834

Incidence of Invasive and Noninvasive Pneumococcal Pneumonia Hospitalizations in People Aged ≥50 Years: Assessing Variability Across Denmark and Spain.
López-Lacort M, Amini M, Emborg HD, Nielsen J, McDonald SA, Valentiner-Branth P, Díez-Domingo J, Orrico-Sánchez A.
J Infect Dis. 2024 Sep 23;230(3):e559-e567. doi: 10.1093/infdis/jiae088.
PMID: 38459772 Free PMC article.

Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
Moustsen-Helms IR, Bager P, Larsen TG, Møller FT, Vestergaard LS, Rasmussen M, Hansen CH; SSI-DMC Study Group.
Lancet Infect Dis. 2024 Sep;24(9):964-973. doi: 10.1016/S1473-3099(24)00220-2. Epub 2024 May 15.
PMID: 38761806

Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark.
Nielsen KF, Nielsen LB, Dalby T, Lomholt FK, Slotved HC, Fuursted K, Harboe ZB, Jørgensen CS, Valentiner-Branth P.
Emerg Infect Dis. 2024 Jun;30(6):1164-1172. doi: 10.3201/eid3006.230975.
PMID: 38781925 Free PMC article.

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.
Bennett JC, Deloria Knoll M, Kagucia EW, Garcia Quesada M, Zeger SL, Hetrich MK, Yang Y, Herbert C, Ogyu A, Cohen AL, Yildirim I, Winje BA, von Gottberg A, Viriot D, van der Linden M, Valentiner-Branth P, Suga S, Steens A, Skoczynska A, Sinkovec Zorko N, Scott JA, Savulescu C, Savrasova L, Sanz JC, Russell F, Ricketson LJ, Puentes R, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, MacDonald L, Lepp T, Ladhani SN, Kristinsson KG, Kozakova J, Klein NP, Jayasinghe S, Ho PL, Hilty M, Heyderman RS, Hasanuzzaman M, Hammitt LL, Guevara M, Grgic-Vitek M, Gierke R, Georgakopoulou T, Galloway Y, Diawara I, Desmet S, De Wals P, Dagan R, Colzani E, Cohen C, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Bigogo G, Ampofo K, O'Brien KL, Feikin DR, Hayford K; PSERENADE Team.
Lancet Infect Dis. 2024 Dec 17:S1473-3099(24)00665-0. doi: 10.1016/S1473-3099(24)00665-0. Online ahead of print.
PMID: 39706204

Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Muñoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, Eugenia León M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacón G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL, Deloria Knoll M; PSERENADE Team.
Lancet Infect Dis. 2024 Dec 17:S1473-3099(24)00588-7. doi: 10.1016/S1473-3099(24)00588-7. Online ahead of print.
PMID: 39706205

Identification of subgroups in the Danish population for targeted human papillomavirus vaccination efforts.
Voss SS, Nørgaard SK, Valentiner-Branth P.
Vaccine. 2023 May 26;41(23):3525-3533. doi: 10.1016/j.vaccine.2023.04.060. Epub 2023 May 2.
PMID: 37142460

Sociodemographic differences in Covid-19 vaccine uptake in Denmark: a nationwide register-based cohort study.
Gram MA, Moustsen-Helms IR, Valentiner-Branth P, Emborg HD.
BMC Public Health. 2023 Feb 24;23(1):391. doi: 10.1186/s12889-023-15301-x.
PMID: 36829138 Free PMC article.